Join ASFA!

Sponsorship, Symposia, Marketing and Exhibiting

ASFA 2009 Annual Meeting

The 30th Annual Meeting of the American Society for Apheresis will take place May 20 - 23, 2009 at the Sheraton San Diego Hotel and Marina in San Diego, California.

Corporate Opportunities Prospectus

The ASFA 2009 Annual Meeting Corporate Opportunities Prospectus details the sponsorship, symposia, marketing, and exhibiting opportunities available in conjunction with the 30th Annual Meeting. 

The Corporate Opportunities outlined in this Prospectus provide a unique way to show your support of ASFA and to increase your visibility in the premier apheresis meeting.  Market directly to your target demographic and build valuable professional relationships with experts in apheresis, blood banking, transfusion medicine, and cellular therapy.

Please review this Prospectus and contact the ASFA Head Office with your questions or requests.

Conference History

ASFA, officially formed in 1981, has been the proud host to 28 highly successful scientific conferences. Last year's Annual Meeting in Nashville had almost 700 participants, including registered delegates, exhibitors and other corporate representatives. The meeting is the only one of its kind that offers a focus on apheresis medicine in both the donor and patient settings. It is a key educational and networking event for physicians, scientists, and allied health professionals in the field of apheresis medicine.

Delegates

ASFA Annual Meeting delegates are evenly divided between MD and/or PhD clinicians and scientists and allied health professionals who practice donor or therapeutic apheresis medicine. Other delegates also include regulatory professionals, corporate management, and marketing personnel. The majority of delegates practice in the US. ASFA expects participants of the 2009 Annual Meeting to be broken down similar to past years.

Past Sponsors and Exhibitors

Sponsors and exhibitors from the past five meetings include:

  • AABB
  • American Red Cross
  • American Society for Clinical Pathology
  • Amgen
  • Andover Coated Products
  • Angiodynamics
  • Apheresis Care Group
  • Apheresis News
  • Arlington Scientific
  • Audit MicroControls
  • Bard Access Systems
  • Baxter Healthcare Corporation
  • B. Braun Medical
  • bioMerieux
  • CHF Solutions
  • Cottonimages.com
  • Dideco S.P.A.
  • Fenwal Blood Technologies
  • Fresenius HemoCare
  • Fresenius Medical Care Extracorporeal Alliance
  • Gambro BCT
  • GenesisBPS
  • Haemonetics Corporation
  • Haemoscope Corporation
  • HDOX Bioinformatics
  • HemaMetrics Corporation
  • HMP
  • International Society for Cellular Therapy
  • John Wiley & Sons
  • JMS North America Corporation
  • Kaneka Pharma America
  • MedComp
  • Medical Visual Creations
  • National Marrow Donor Program
  • Navigant Biotechnologies
  • New York Blood Center
  • OccuLogix
  • Otsuka America Pharmaceuticals
  • Pall Medical
  • PhereSys Therapeutics
  • Renal Care Group
  • SEBRA
  • Separation Technology
  • Shamrock Scientific Specialty Systems
  • Talisman
  • Terumo Medical Corporation
  • Therakos
  • United Blood Services Therapeutic Apheresis Program/Stem Cell Program